4:09 pm Edwards Lifesciences beats by $0.07, reports revs in-line; guides Q2 EPS in-line, revs in-line; guides FY14 EPS in-line, reaffirms FY14 revs guidance
View todays social media effects on EW
View the latest stocks trending across Twitter. Click to view dashboard